Laurus Labs stock rises 30 percent on FY26 results

Laurus Labs reported strong financial results for fiscal 2026, driving a 30 percent gain in its share price. Growth in contract manufacturing and a better product mix supported the performance.

The Indian pharmaceutical company is directing ₹3,000 crore toward capacity expansion. Focus areas include high-value contract development and manufacturing services.

These services are expected to double their share of total revenue by 2030. Analysts have raised earnings estimates while keeping a buy recommendation on the stock.

The results reflect continued expansion across multiple business segments. Brokerage firms remain positive on the outlook for the company.

Makala yanayohusiana

Sun Pharmaceutical Industries posted robust revenue and profit increases for the March quarter. The company noted pressure on EBITDA margins due to higher investments and reduced milestone income. Outlook for the next fiscal year points to steady but moderated expansion.

Imeripotiwa na AI

Gland Pharma shares reached a new 52-week high after the company reported strong results for the March quarter and full year. The European unit Cenexi showed signs of recovery while new product launches and capacity additions supported the outlook.

Ralph Lauren reported strong financial results for the fourth quarter and full fiscal year, surpassing revenue expectations and crossing the $8 billion mark for the first time. The company credited consumer loyalty and strategic execution for the gains across key regions.

Imeripotiwa na AI

Paras Defence and Space Technologies shares rose 28 percent over three trading sessions amid growing optimism in India's defence manufacturing sector. The gains extend an ongoing rally fueled by increased domestic production and exports.

Ijumaa, 12. Mwezi wa sita 2026, 02:10:37

Motilal Oswal shares jump 5% on UBS buy rating

Ijumaa, 15. Mwezi wa tano 2026, 02:19:34

ARS Pharmaceuticals reports strong start to 2026 in earnings call

Jumatano, 13. Mwezi wa tano 2026, 12:53:51

Aytu biopharma holds fiscal 2026 q3 earnings call

Jumatano, 13. Mwezi wa tano 2026, 07:41:49

Mutual funds boost pharma and nbfc holdings in april

Jumatano, 6. Mwezi wa tano 2026, 13:25:46

Linamar highlights mobility growth in Q1 earnings call

Ijumaa, 1. Mwezi wa tano 2026, 05:43:00

Nine BSE smallcap stocks surged up to 170% with strong Q4 profits

Jumatano, 29. Mwezi wa nne 2026, 10:18:47

Puig reports 4.7% revenue growth in Q1 2026

Jumapili, 26. Mwezi wa nne 2026, 12:25:49

Sun Pharma shares jump over 9% on $11.75 billion Organon acquisition

Jumatano, 22. Mwezi wa nne 2026, 16:12:19

L’Oréal’s Q1 2026 revenues rise 7.6% to €12.2 billion

Jumapili, 29. Mwezi wa tatu 2026, 00:26:27

Goldman Sachs’ India portfolio falls 36% in FY26

 

 

 

Tovuti hii inatumia vidakuzi

Tunatumia vidakuzi kwa uchambuzi ili kuboresha tovuti yetu. Soma sera ya faragha yetu kwa maelezo zaidi.
Kataa